With this aim, we generated iPSC lines with single or bi-allelic inactivation of NF2 by combining the direct reprogramming of human primary vestibular schwannoma cells, with the use of CRISPR/Cas9 NF2 gene editing (Fig. 1A). The gene discussed is NF2; the disease is Vestibular schwannoma.